Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Oct 6;10(10):e040129.
doi: 10.1136/bmjopen-2020-040129.

Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis

Affiliations
Meta-Analysis

Sex difference in coronavirus disease (COVID-19): a systematic review and meta-analysis

Biruk Beletew Abate et al. BMJ Open. .

Abstract

Objective: To assess the sex difference in the prevalence of COVID-19 confirmed cases.

Design: Systematic review and meta-analysis.

Setting: PubMed, Cochrane Library and Google Scholar were searched for related information. The authors developed a data extraction form on an Excel sheet and the following data from eligible studies were extracted: author, country, sample size, number of female patients and number of male patients. Using STATA V.14 for analysis, the authors pooled the overall prevalence of men and/or women using a random-effect meta-analysis model. The authors examined the heterogeneity in effect size using Q statistics and I2 statistics. Subgroup and sensitivity analyses were performed. Publication bias was also checked.

Participants: Studies on COVID-19 confirmed cases were included.

Intervention: Sex (male/female) of COVID-19 confirmed cases was considered.

Primary and secondary outcome measures: The primary outcome was prevalence of COVID-19 among men and women.

Results: A total of 57 studies with 221 195 participants were used in the analysis. The pooled prevalence of COVID-19 among men was found to be 55.00 (51.43-56.58, I2=99.5%, p<0.001). Sensitivity analysis showed the findings were not dependent on a single study. Moreover, a funnel plot showed symmetrical distribution. Egger's regression test p value was not significant, which indicates absence of publication bias in both outcomes.

Conclusions: The prevalence of symptomatic COVID-19 was found to be higher in men than in women. The high prevalence of smoking and alcohol consumption contributed to the high prevalence of COVID-19 among men. Additional studies on the discrepancies in severity and mortality rate due to COVID-19 among men and women and the associated factors are recommended.

Keywords: epidemiology; immunology; infectious diseases.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
PRISMA flow diagram shows the results of the search and the reasons for exclusion. PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 2
Figure 2
Forest plot showing the pooled prevalence of COVID-19 confirmed cases among men. ES, Estimate.
Figure 3
Figure 3
Sensitivity analysis of the pooled prevalence of COVID-19 confirmed cases among men.

References

    1. Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506. 10.1016/S0140-6736(20)30183-5 - DOI - PMC - PubMed
    1. Ong SWX, Tan YK, Chia PY, et al. . Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA 2020;323:1610–2. 10.1001/jama.2020.3227 - DOI - PMC - PubMed
    1. Jiang X, Rayner S, Luo M-H, Luo Min‐Hua. Does SARS-CoV-2 has a longer incubation period than SARS and MERS? J Med Virol 2020;92:476–8. 10.1002/jmv.25708 - DOI - PMC - PubMed
    1. Li R, Pei S, Chen B, et al. . Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2). Science 2020;368:489–93. 10.1126/science.abb3221 - DOI - PMC - PubMed
    1. Thompson R. Pandemic potential of 2019-nCoV. Lancet Infect Dis 2020;20:280. 10.1016/S1473-3099(20)30068-2 - DOI - PMC - PubMed

LinkOut - more resources